Influence ofCYP2C8*2on the Pharmacokinetics of Pioglitazone in Healthy African-American Volunteers

Impact of theCYP2C8*3polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone

(2012) Christina L. Aquilante et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Human Genetic Variation Is Associated With Plasmodium falciparum Drug Resistance

(2011) G. M. Paganotti et al.   JOURNAL OF INFECTIOUS DISEASES

Functional characterization of five CYP2C8 variants and prediction of CYP2C8 genotype-dependent effects onin vitroandin vivodrug–drug interactions

(2010) Yiwen Gao et al.   XENOBIOTICA

The Role of Human CYP2C8 and CYP2C9 Variants in Pioglitazone MetabolismIn Vitro

(2009) Eugen Muschler et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies

(2009) Elizabeth B Daily et al.   PHARMACOGENOMICS

Effect of Concomitant Artesunate Administration and Cytochrome P4502C8 Polymorphisms on the Pharmacokinetics of Amodiaquine in Ghanaian Children with Uncomplicated Malaria

(2008) G. O. Adjei et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

No significant effect ofSLCO1B1polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone

(2007) Annikka Kalliokoski et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY